Ohio board withdraws proposed hydroxychloroquine rule for treatment of COVID-19

Ohio board withdraws proposed hydroxychloroquine rule for treatment of COVID-19
Dozens of scientists questioned irregularities and improbable findings in the numbers. (Source: CNN)

CINCINNATI (FOX19) - The State of Ohio Board of Pharmacy has withdrawn their proposed hydroxychloroquine rule to prohibit the selling or dispensing of hydroxychloroquine or chloroquine for the treatment or prevention of COVID-19

Their withdrawal came shortly after Ohio Gov. Mike DeWine asked the board to halt their new rule.

The board said the decision was made “as a result of the feedback received by the medical and patient community and at the request of Governor DeWine.”

“This will allow the board to reexamine the issue with the assistance of the State Medical Board of Ohio, clinical experts, and other stakeholders to determine appropriate next steps,” The State of Ohio Board of Pharmacy said.

The rule, which can be read in full here, will not take effect at this time.

DeWine said he agrees with the statement from Commissioner of the FDA Dr. Steven Hahn that the decision about prescribing hydroxychloroquine to treat COVID-19 should be between a doctor and a patient.

Copyright 2020 WXIX. All rights reserved.